HEALTHeUNIVERSE, Inc. (HLUN) Stock
Healtheuniverse, Inc. operates as a biotechnology firm dedicated to exploring, creating, and bringing to market a diverse range of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.
Valuation
Financials & Margins
Valuation & Return Ratios
Peer Comparison
About HEALTHeUNIVERSE, Inc.
Healtheuniverse, Inc. operates as a biotechnology firm dedicated to exploring, creating, and bringing to market a diverse range of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. A key focus involves advancing regenerative medicine and stem cell treatments, specifically employing non-embryonic adult stem cells. These therapies are designed for applications across multiple medical specialties, such as reconstructive and plastic surgery, orthopedics, vascular procedures, heart surgery, and wound management. Additionally, the company extends its expertise through consulting services, assisting various enterprises with strategic marketing, organizational structuring, and securing funding for their initiatives. Established in 2001, its primary operational base is located in Covina, California.
HEALTHeUNIVERSE, Inc. (HLUN) stock trades at $0.00 with a market capitalization of $11778. The stock is valued at a price-to-earnings (P/E) ratio of 0.10, price-to-book of 0.02, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, HEALTHeUNIVERSE, Inc. generates an operating margin of 5.01%, a net profit margin of 8.88%.
Official website: domains.atom.com/lpd/name/www.healtheuniverse.com